DAY TWO: Regulation & Commercialization
- Terry Kippley - President & CEO, The Council of Producers and Distributors of Agrotechnology (CPDA)
- Glenda Humiston - Vice President, Agriculture and Natural Resources, University of California
Drawing on the development of a global regulatory compendium covering 32 countries, Terry Stone will examine what regulatory professionals need to understand when entering a new market—and why the written data requirements often tell only part of the story.
Beyond the Technical Dossier
Why social, political, institutional, and communication dynamics can be as important as the scientific data package in determining regulatory outcomes.
A 32-Country Perspective
Comparative insights across regulatory systems, ranging from Brazil’s increasingly streamlined pathways to the prolonged and complex approval processes encountered in Europe.
Practical Market Entry
What a regulatory professional should understand on Day One when evaluating a new country, including regulatory authority, product classification, data expectations, timelines, local representation, institutional capacity, and unwritten practices.
Free and Accessible Regulatory Knowledge
How Terry’s collaboration with the Agricultural & Food Systems Institute is making global regulatory intelligence freely available to support industry, regulators, researchers, and capacity-building initiatives.
The United States in Global Context
Where the U.S. EPA biopesticide system sits within the broader international regulatory landscape—and what the United States may learn from approaches being used in other markets.
- Terry Stone - Founder, Stone Biological Solutions
Whilst Brazil revolutionised biocontrol approvals with 12-18 month timelines through federal harmonisation, the USA presents a stark contrast: 50 different state regulations, 50 different laws, and NO federal definition for biostimulants. This panel brings together regulatory experts from both regions to reveal what the USA can learn from LATAM's policy success—and the practical strategies biocontrol companies need to navigate America's fragmented regulatory maze.
Key Discussion Points:
USA's Regulatory Reality: Multi-state market access strategies, hidden costs of regulatory inconsistency, and what the industry desperately needs from policymakers
LATAM's Success Story: How Brazil's streamlined regulatory framework accelerated biocontrol adoption and what policy alignment with producers looks like in practice
Comparative Intelligence: Actionable insights for companies operating across both markets—from EPA navigation to leveraging Brazil's 12-18 month advantage
Future Vision: What regulatory harmonisation could mean for USA biocontrol innovation and competitiveness
- Shujian Zhang - Founder, Nexus BioStrategy
- Manojit Basu - Vice President, Science Policy and Regulatory Affairs, Croplife America
- Megan Priest - Founder and Principal Consultant, Straticide Consulting
- Francys Vilella - Co-Founder, CESIS Ltda
- Terry Kippley - President & CEO, The Council of Producers and Distributors of Agrotechnology (CPDA)
- Terry Kippley - President & CEO, The Council of Producers and Distributors of Agrotechnology (CPDA)
- Kristen Sukalac - Secretary General, Biocontrol Coalition
- Matt Hoffman - Senior Director of Innovation, Western Growers Association
- Leah Zorrilla, Ph.D. - Director, Regulatory Toxicology North America, Bayer Crop Science
- Delaney Miller - Postdoctoral Fellow Handelsman Lab Wisconsin Institute for Discovery, Department of Plant Pathology, University of Wisconsin-Madison
- Terry Kippley - President & CEO, The Council of Producers and Distributors of Agrotechnology (CPDA)
- Terry Kippley - President & CEO, The Council of Producers and Distributors of Agrotechnology (CPDA)
- Matthew Pye - Biologicals Subject Matter Expert, FMC Corp
Unveil primary research findings on biopesticide adoption barriers across American row crops and specialty crops, with quantitative data on why farmers hesitate to adopt biological solutions
Analyse the psychological, economic, and practical obstacles preventing biocontrol commercialisation
Present data-driven strategies for building farmer confidence and demonstrating ROI, drawing from proven methodologies that have scaled agricultural technology companies
- Cam Camfield - Founder & CEO, Stratovation Group
- Rick Foell - General Manager, Delta Growers Inc.
- Terry Kippley - President & CEO, The Council of Producers and Distributors of Agrotechnology (CPDA)
- Terry Kippley - President & CEO, The Council of Producers and Distributors of Agrotechnology (CPDA)
Discuss what data convinces farmers, retailers, and regulators that biocontrol products work
Examine trial design, statistical approaches, and communicating results effectively
Six countries, one question: A survey of 3,675 consumers across Austria, Denmark, Estonia, France, Greece, and the Netherlands tested purchase intention for biopesticide-grown tomatoes as information was revealed in stages.
Awareness beats everything else: Among four attitudinal drivers tested (awareness and credibility, perceived importance, regulatory support, and label perception), prior awareness and credibility was the strongest predictor of firm purchase intention.
One story, different endings: While awareness and credibility led overall, its influence on purchase intention varied notably from country to country, highlighting the need for market-specific messaging.
- João Godinho - Ph.D. Candidate, Agricultural Economics and Rural Policy Group, Wageningen University
Provide insights into what venture capital, strategic investors, and grant programmes look for in biocontrol ventures
Discuss valuation, milestones, and building investor confidence in biological solutions
- Terry Kippley - President & CEO, The Council of Producers and Distributors of Agrotechnology (CPDA)
